Key result
Multidisciplinary care enables safe, uneventful delivery in severe obstructive hypertrophic cardiomyopathy.
Why the study?
Pregnancy in women with hypertrophic obstructive cardiomyopathy poses risks of adverse complications such as arrhythmia and heart failure requiring close monitoring and management.
Case Report (n=1)
No
Demonstrates that with close multidisciplinary monitoring and guideline-directed medical therapy, high-risk pregnant women with obstructive HCM can undergo successful vaginal delivery.
May support multidisciplinary care enabling safe delivery in obstructive HCM pregnancy; leaves open generalizability from single case.
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiomyopathy, with an estimated prevalence of 1 in 500 people. Despite overall favorable outcomes with modern treatment and early diagnosis of disease, adverse complications could occur during times of physiological stress like pregnancy. Complications of HCM include sudden cardiac death, heart failure, and arrhythmia. We report the case of a 32-year-old pregnant woman with obstructive HCM, presenting with recurrent episodes of ventricular arrhythmia despite medical therapy. This case exhibits how close monitoring and proper management during pregnancy according to the latest recommendations, resulted in a successful and uneventful delivery.
No takes yet. Share an insight, caveat, or question.
Assamti et al. (2021) conducted a case report in Hypertrophic obstructive cardiomyopathy in pregnancy (n=1). Multidisciplinary management and beta-blocker therapy was evaluated on Maternal and fetal outcome. Close monitoring and proper multidisciplinary management of a pregnant woman with obstructive hypertrophic cardiomyopathy resulted in a successful and uneventful delivery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: